Joseph M. Keane

TNF-blocking agents and tuberculosis: new drugs illuminate an old topic.

Tuberculosis reactivation during immunosuppressive therapy in rheumatic diseases: diagnostic and therapeutic strategies.

Untreated chronic tuberculous salpingitis followed by successful in vitro fertilization conception and congenital tuberculosis.

Sharpening nature's tools for efficient tuberculosis control: A review of the potential role and development of host-directed therapies and strategies for targeted respiratory delivery.

Inhalable poly(lactic-co-glycolic acid) (PLGA) microparticles encapsulating all-trans-Retinoic acid (ATRA) as a host-directed, adjunctive treatment for Mycobacterium tuberculosis infection.